SK281293B6 - Farmaceutický prípravok vhodný na zmiernenie bolesti a spôsob jeho prípravy - Google Patents

Farmaceutický prípravok vhodný na zmiernenie bolesti a spôsob jeho prípravy Download PDF

Info

Publication number
SK281293B6
SK281293B6 SK1661-96A SK166196A SK281293B6 SK 281293 B6 SK281293 B6 SK 281293B6 SK 166196 A SK166196 A SK 166196A SK 281293 B6 SK281293 B6 SK 281293B6
Authority
SK
Slovakia
Prior art keywords
triacylglycerol
pharmaceutical composition
pharmaceutical
pharmaceutical preparation
sphingolipids
Prior art date
Application number
SK1661-96A
Other languages
English (en)
Slovak (sk)
Other versions
SK166196A3 (en
Inventor
Arne Brodin
Anders Carlsson
Bengt Herslf
Martin Nicklasson
Lisbeth Rydhag
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of SK166196A3 publication Critical patent/SK166196A3/sk
Publication of SK281293B6 publication Critical patent/SK281293B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1661-96A 1994-07-12 1995-06-21 Farmaceutický prípravok vhodný na zmiernenie bolesti a spôsob jeho prípravy SK281293B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402453A SE9402453D0 (sv) 1994-07-12 1994-07-12 New pharmaceutical preparation
PCT/SE1995/000760 WO1996001637A1 (en) 1994-07-12 1995-06-21 New pharmaceutical preparation for pain management

Publications (2)

Publication Number Publication Date
SK166196A3 SK166196A3 (en) 1997-08-06
SK281293B6 true SK281293B6 (sk) 2001-02-12

Family

ID=20394703

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1661-96A SK281293B6 (sk) 1994-07-12 1995-06-21 Farmaceutický prípravok vhodný na zmiernenie bolesti a spôsob jeho prípravy

Country Status (30)

Country Link
US (1) US5912271A (es)
EP (1) EP0767669B1 (es)
JP (1) JPH10502631A (es)
KR (1) KR100399522B1 (es)
CN (1) CN1236759C (es)
AT (1) ATE202478T1 (es)
AU (1) AU686414B2 (es)
BR (1) BR9508373A (es)
CA (1) CA2193992A1 (es)
CZ (1) CZ379496A3 (es)
DE (1) DE69521512T2 (es)
DK (1) DK0767669T3 (es)
EE (1) EE9700008A (es)
ES (1) ES2160712T3 (es)
FI (1) FI970101A (es)
GR (1) GR3036745T3 (es)
HU (1) HUT76809A (es)
IL (1) IL114446A (es)
IS (1) IS4397A (es)
MX (1) MX9700272A (es)
NO (1) NO970067L (es)
NZ (1) NZ289954A (es)
PL (1) PL180504B1 (es)
PT (1) PT767669E (es)
SE (1) SE9402453D0 (es)
SK (1) SK281293B6 (es)
TR (1) TR199500847A2 (es)
TW (1) TW410159B (es)
WO (1) WO1996001637A1 (es)
ZA (1) ZA955327B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4467789B2 (ja) 1997-09-18 2010-05-26 パシラ ファーマシューティカルズ インコーポレーテッド 持続放出性リポソーム麻酔組成物
CA2309548A1 (en) 1997-11-14 1999-05-27 Skyepharma Inc. Production of multivesicular liposomes
SE9800729L (sv) * 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
SE515982C2 (sv) * 1998-03-06 2001-11-05 Lipocore Holding Ab Användning av en olja-i-vatten emulsion som bärare för framställning av en topikal kräm eller lotion
US6277413B1 (en) 1998-07-17 2001-08-21 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
EP1043016B1 (en) 1999-03-30 2014-08-20 Sodic Sa A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
DE60239528D1 (de) * 2001-05-01 2011-05-05 Corium International Redwood City Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
US8728445B2 (en) 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions
WO2002089849A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
AU2002322024B2 (en) * 2001-05-31 2008-05-08 Pacira Pharmaceuticals, Inc. Encapsulation of nanosuspensions in liposomes and microspheres
GB0119859D0 (en) * 2001-08-15 2001-10-10 Qinetiq Ltd Eye tracking system
SE0102933D0 (sv) * 2001-09-04 2001-09-04 Lipocore Holding Ab Lipid carrier
WO2003020318A1 (en) * 2001-09-04 2003-03-13 Lipocore Holding Ab A topical w/o-emulsion composition
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
AU2005210637B2 (en) 2004-01-30 2010-09-16 A.V. Topchiev Institute Of Petrochemical Synthesis Rapidly dissolving film for delivery of an active agent
EP1791575B1 (en) * 2004-08-05 2014-10-08 Corium International, Inc. Adhesive composition
US8895084B2 (en) 2004-12-23 2014-11-25 Colgate-Palmolive Company Oral care composition containing extract of unoxidized Camellia
WO2009061497A1 (en) 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
WO2009066685A1 (ja) * 2007-11-19 2009-05-28 Snow Brand Milk Products Co., Ltd. 感覚改善剤
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
CN111840553A (zh) * 2019-04-15 2020-10-30 湖州依诺唯新药物制剂有限公司 脂性药物制剂及其应用
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
GB2163956B (en) * 1984-09-08 1988-03-30 Ile De France Percutaneous anaesthetic composition for topical application
GB8712518D0 (en) * 1987-05-28 1987-07-01 Univ Belfast Unit-dose film composition
AU4216089A (en) * 1988-08-12 1990-03-05 Joel E. Bernstein Method and composition for treating and preventing dry skin disorders
FR2661331A1 (fr) * 1990-04-30 1991-10-31 Oreal Composition cosmetique ou dermopharmaceutique contenant des vesicules formees par un melange phospholipides/glycolipides.
JPH05163153A (ja) * 1991-12-19 1993-06-29 Q P Corp スフィンゴ脂質組成物
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
CA2137001C (en) * 1992-06-19 1999-05-04 Peter M. Elias Lipids for epidermal moisturization and repair of barrier function
FR2692781B1 (fr) * 1992-06-24 1995-05-05 Sederma Sa Nouvelles compositions cosmétiques contenant des sphingomyélines et autres lipides complexes.

Also Published As

Publication number Publication date
ATE202478T1 (de) 2001-07-15
HU9700056D0 (en) 1997-02-28
DK0767669T3 (da) 2001-07-23
NZ289954A (en) 1997-12-19
FI970101A0 (fi) 1997-01-10
IL114446A0 (en) 1995-11-27
NO970067D0 (no) 1997-01-08
AU686414B2 (en) 1998-02-05
IS4397A (is) 1996-12-17
US5912271A (en) 1999-06-15
NO970067L (no) 1997-01-08
EE9700008A (et) 1997-06-16
CN1236759C (zh) 2006-01-18
SK166196A3 (en) 1997-08-06
SE9402453D0 (sv) 1994-07-12
PT767669E (pt) 2001-10-30
DE69521512T2 (de) 2001-10-25
PL180504B1 (pl) 2001-02-28
IL114446A (en) 1999-08-17
JPH10502631A (ja) 1998-03-10
TW410159B (en) 2000-11-01
PL318172A1 (en) 1997-05-26
TR199500847A2 (tr) 1996-06-21
AU2994395A (en) 1996-02-09
KR100399522B1 (ko) 2004-02-18
EP0767669B1 (en) 2001-06-27
GR3036745T3 (en) 2001-12-31
WO1996001637A1 (en) 1996-01-25
DE69521512D1 (de) 2001-08-02
CZ379496A3 (en) 1997-06-11
CA2193992A1 (en) 1996-01-25
EP0767669A1 (en) 1997-04-16
HUT76809A (en) 1997-11-28
CN1152873A (zh) 1997-06-25
ES2160712T3 (es) 2001-11-16
MX9700272A (es) 1997-05-31
FI970101A (fi) 1997-01-10
KR970704453A (ko) 1997-09-06
BR9508373A (pt) 1997-10-28
ZA955327B (en) 1996-01-12

Similar Documents

Publication Publication Date Title
SK281293B6 (sk) Farmaceutický prípravok vhodný na zmiernenie bolesti a spôsob jeho prípravy
US5231090A (en) Treatment for hypercholesterolemia
US4839159A (en) Topical L-carnitine composition
EP0789584B1 (de) Applikation von sod in liposomen
EP0786251A2 (en) Topical preparation containing a suspension of solid lipid particles
EP2744474B1 (de) Medizinische hautschutz-zusammensetzung mit einer die hautbarriere verbessernden wirkstoffkombination
CA2406570C (en) Dermal compositions containing coenzyme q as the active ingredient
EP0098743A1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
PL185294B1 (pl) Przeciwświądowe kompozycje kosmetyczne i/lub farmaceutyczne, ich zastosowanie do wytwarzania leków i sposób ich wytwarzania
EP1069886B1 (en) Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance
UA76415C2 (uk) Застосування похідних бігуаніду для отримання лікарського препарату з ефектом загоєння ран
US5916918A (en) Method for treating a skin injury comprising topically applying acetylsalicylic acid
EP1392243B1 (de) Pharmazeutische zusammensetzung
JP3524169B2 (ja) ニキビ改善用皮膚化粧料
US9757360B2 (en) Pharmaceutical composition comprising a ryanodine receptor antagonist for facilitating wound healing
US6187815B1 (en) Methods and compositions for the promotion of hair growth
RU2186561C2 (ru) Крем для сухой и нормальной кожи лица
RU2033163C1 (ru) Средство, стимулирующее ранозаживление и/или улучшающее обмен веществ в покровных тканях
WO2023121603A1 (en) Product enabling disinfection and protection of the skin
JPS61260015A (ja) 外用剤
JPS61194015A (ja) 外用剤
JPH0529008B2 (es)
PL203478B1 (pl) Zastosowanie pochodnych biguanidu i ich soli do wytwarzania leku do bliznowacenia